Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiome.

[1]  E. Volkmann.  Is there a role for the microbiome in systemic sclerosis? , 2022, Expert review of clinical immunology.

[2]  Tytus D. Mak,et al.  Crohn’s disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome , 2022, Genome medicine.

[3]  P. Clements,et al.  Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent Cohorts , 2022, ACR open rheumatology.

[4]  A. Valdes,et al.  RETRACTED ARTICLE: Role of the gut microbiome in chronic diseases: a narrative review , 2021, European Journal of Clinical Nutrition.

[5]  Yubin Luo,et al.  Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention , 2021, Frontiers in Immunology.

[6]  Y. Leung,et al.  The microbiome and systemic sclerosis: A review of current evidence. , 2021, Best practice & research. Clinical rheumatology.

[7]  A. Forbes,et al.  Low FODMAP Diet for Functional Gastrointestinal Symptoms in Quiescent Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials , 2020, Nutrients.

[8]  D. Vandeputte,et al.  Effects of Low and High FODMAP Diets on Human Gastrointestinal Microbiota Composition in Adults with Intestinal Diseases: A Systematic Review , 2020, Microorganisms.

[9]  Matthias Scholz,et al.  Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics. , 2020, Clinical nutrition.

[10]  D. Wuttge,et al.  Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation—a prospective, observational study , 2020, Arthritis Research & Therapy.

[11]  B. Posteraro,et al.  Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status. , 2020, Clinical and experimental rheumatology.

[12]  Collins Wenhan Chu,et al.  A double-blind randomized placebo-controlled trial of probiotics in systemic sclerosis associated gastrointestinal disease. , 2019, Seminars in arthritis and rheumatism.

[13]  C. Kayser,et al.  Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial. , 2019, Rheumatology.

[14]  F. Levenez,et al.  Effects of Low-FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial. , 2019, Gastroenterology.

[15]  J. Pauling,et al.  The efficacy of dietary intervention on gastrointestinal involvement in systemic sclerosis: A systematic literature review. , 2019, Seminars in arthritis and rheumatism.

[16]  C. Derk,et al.  Mortality and survival in systemic sclerosis: a review of recent literature , 2018, Current opinion in rheumatology.

[17]  C. Manichanh,et al.  Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders. , 2018, Gastroenterology.

[18]  E. Volkmann,et al.  Update on the Gastrointestinal Microbiome in Systemic Sclerosis , 2018, Current Rheumatology Reports.

[19]  J. Vadivelu,et al.  Impact of Klebsiella pneumoniae in lower gastrointestinal tract diseases , 2018, Journal of digestive diseases.

[20]  E. Tiniakou,et al.  Translocation of a gut pathobiont drives autoimmunity in mice and humans , 2018, Science.

[21]  V. Patrone,et al.  Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement , 2017, Scientific Reports.

[22]  C. Denton,et al.  SYSTEMIC SCLEROSIS , 2008 .

[23]  A. Naska,et al.  Dietary assessment methods in epidemiological research: current state of the art and future prospects , 2017, F1000Research.

[24]  E. Mayer,et al.  Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts , 2017, BMJ open gastroenterology.

[25]  H. Staudacher.  Nutritional, microbiological and psychosocial implications of the low FODMAP diet , 2017, Journal of gastroenterology and hepatology.

[26]  G. Jönsson,et al.  Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease , 2016, Arthritis Research & Therapy.

[27]  D. McGovern,et al.  Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium , 2016, Arthritis & rheumatology.

[28]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[29]  Na-Ri Shin,et al.  Proteobacteria: microbial signature of dysbiosis in gut microbiota. , 2015, Trends in biotechnology.

[30]  P. Ducrotte,et al.  Fructose Malabsorption in Systemic Sclerosis , 2015, Medicine.

[31]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[32]  J. Braun,et al.  Sampling of Intestinal Microbiota and Targeted Amplification of Bacterial 16S rRNA Genes for Microbial Ecologic Analysis , 2014, Current protocols in immunology.

[33]  William A. Walters,et al.  Conducting a Microbiome Study , 2014, Cell.

[34]  A. Kostic,et al.  The microbiome in inflammatory bowel disease: current status and the future ahead. , 2014, Gastroenterology.

[35]  M. Mayes,et al.  2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative , 2013, Annals of the rheumatic diseases.

[36]  R. Knight,et al.  UniFrac: an effective distance metric for microbial community comparison , 2011, The ISME Journal.

[37]  R. Hays,et al.  Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. , 2009, Arthritis and rheumatism.

[38]  W. Graf,et al.  Lower gastrointestinal symptoms and quality of life in patients with systemic sclerosis: a population-based study , 2009, European journal of gastroenterology & hepatology.

[39]  R. Knight,et al.  Species divergence and the measurement of microbial diversity. , 2008, FEMS microbiology reviews.

[40]  J. Walter.  Ecological Role of Lactobacilli in the Gastrointestinal Tract: Implications for Fundamental and Biomedical Research , 2008, Applied and Environmental Microbiology.

[41]  H. Sallam,et al.  Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma) , 2006, Alimentary pharmacology & therapeutics.

[42]  D. Midthune,et al.  Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : the Eating at America's Table Study. , 2001, American journal of epidemiology.

[43]  P. Gibson,et al.  A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. , 2014, Gastroenterology.